https://www.selleckchem.com/pr....oducts/gsk2193874.ht
, opening the way to new antimicrobial strategies in CF patients.Disease states are often linked to large scale changes in microbial community structure that obscure the contributions of individual microbes to disease. Establishing a mechanistic understanding of how microbial community structure contribute to certain diseases, however, remains elusive thereby limiting our ability to develop successful microbiome-based therapeutics. Human microbiota-associated (HMA) mice have emerged as a powerful approach for directly testing the inf
Like
Comment
Share
